Marta Abad
@martaabad
I lead medical strategy and launches for rare disease, hematology, and oncology therapies.
SpainWhat I'm looking for
I've led Iberian Medical Affairs for Immedica, Albireo, and Orphalan, driving launch readiness, scientific engagement, and market access collaboration for rare disease therapies across Spain and Portugal. My work has supported launches including Cuprior®, Loargys®, and Bylvay®.
Previously, I led European Gaucher disease medical activities at Sanofi Genzyme and supported global oncology development at Mabxience, including the STELLA bevacizumab biosimilar program across 93 sites in 16 countries. I also helped advance nivolumab, ipilimumab, Esbriet®, and GLP-1 receptor agonists through scientific education, expert engagement, and cross-functional launch work.
Experience
Work history, roles, and key accomplishments
Medical Affairs Director Iberia
Immedica, Albireo & Orphalan
Jan 2019 - Present (7 years 8 months)
Led Iberian Medical Affairs activities across multiple rare disease organizations, supporting launch readiness, scientific engagement and affiliate expansion across Spain and Portugal. Directed pre-launch and launch activities for Cuprior, Loargys and Bylvay, and managed a regional MSL team of 3 professionals.
Led European Medical Affairs activities for Gaucher Disease across multiple affiliates during a strategic transition to Global Medical Affairs structures. Coordinated cross-country scientific initiatives and directed scientific education initiatives including Gaucher Disease University in Milan.
Global Medical Advisor – Oncology
Mabxience (Insud Pharma Group)
Oct 2017 - Aug 2019 (1 year 10 months)
Provided global medical support for the Bevacizumab biosimilar program (STELLA Phase III/IV study), collaborating with investigators and oncology centers across 93 sites in 16 countries. Contributed to protocol review, statistical analysis discussions and pharmacovigilance documentation within global oncology clinical development programs.
Medical Advisor – Oncology & Immuno-Oncology
Jan 2015 - Oct 2017 (2 years 9 months)
Supported the scientific launch and early adoption of Nivolumab and Ipilimumab across renal and uro-oncology indications in Iberia. Partnered with Oncology MSL teams to strengthen scientific engagement and external expert interactions across oncology networks.
Medical Advisor – Rare Diseases
InterMune
Jul 2014 - Jan 2015 (6 months)
Supported pre-launch scientific activities for Esbriet in Spain, contributing to market readiness and scientific adoption within the emerging IPF landscape. Developed scientific education and disease-awareness initiatives for healthcare professionals in a highly specialized rare disease environment.
Contributed to the introduction of the first GLP-1 receptor agonists in Spain, supporting scientific differentiation and stakeholder engagement activities. Developed patient support initiatives later adopted across additional affiliates within the organization.
Education
Degrees, certifications, and relevant coursework
Alcala School of Medicine
Doctor of Medicine, Medicine & Surgery
Earned a Doctor of Medicine degree from Alcala School of Medicine in Madrid.
El Escorial Hospital
Residency, Family Medicine
Completed residency training in Family Medicine at El Escorial Hospital in Madrid.
Puerto Real Hospital
Specialty Training, Clinical Pharmacology
Completed specialty training in Clinical Pharmacology at Puerto Real Hospital in Cádiz.
Tech stack
Software and tools used professionally
Availability
Location
SpainAuthorized to work in
Social media
Job categories
Skills
Interested in hiring Marta?
You can contact Marta and 90k+ other talented remote workers on Himalayas.
Message MartaGet matched with your dream remote job
Sign up now and join over 250,000+ remote workers who receive personalized job alerts, curated job matches, and more for free!
